Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic ...

The liver is central to whole‐body lipid homeostasis, orchestrating the uptake, synthesis, storage and export of fatty acids and their derivatives. Under normal conditions, hepatocytes synthesise ...

Metabolic dysfunction-associated steatohepatitis, or MASH, is a disease at the intersection of metabolic and hepatic dysfunction — creating a complex clinical picture for people living with this ...

Metabolic dysfunction in hepatic disease encompasses a spectrum of disturbances in lipid, carbohydrate and energy metabolism that underlie conditions from simple steatosis to cirrhosis and ...

Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting approximately 30% of the population. The progression from ...

AI-driven gamma-ray precision: Effect of convolutional neural networks on chemotherapy side effects. A phase Ib clinical study to evaluate the safety, tolerability, pharmacokinetic profile and ...